Evidence map›Paper›PMID 41193622›Full record

ArticleScientific reports2025

Phosphoproteomic profiling highlights CDC42 and CDK2 as key players in the regulation of the TGF-β pathway in ALMS1 and BBS1 knockout models.

Brais Bea-Mascato, Girolamo Giudice, Iguaracy Pinheiro-de-Sousa, Carlos Solarat, Pablo Barbeito, Evangelia Petsalaki, Diana Valverde

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Brais Bea-MascatoCINBIO Facultad de Biología, Universidad de Vigo, Campus As Lagoas-Marcosende s/n, 36310, Vigo, Spain.
Girolamo GiudiceEuropean Molecular Biology Laboratory-European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, CB10 1SD, UK.
Iguaracy Pinheiro-de-SousaEuropean Molecular Biology Laboratory-European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, CB10 1SD, UK.
Carlos SolaratCINBIO Facultad de Biología, Universidad de Vigo, Campus As Lagoas-Marcosende s/n, 36310, Vigo, Spain.
Pablo BarbeitoCINBIO Facultad de Biología, Universidad de Vigo, Campus As Lagoas-Marcosende s/n, 36310, Vigo, Spain.
Evangelia PetsalakiEuropean Molecular Biology Laboratory-European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, CB10 1SD, UK.
Diana ValverdeCINBIO Facultad de Biología, Universidad de Vigo, Campus As Lagoas-Marcosende s/n, 36310, Vigo, Spain. dianaval@uvigo.es.

Funding

Instituto de Salud Carlos III PI19/00332Spanish Ministry of Education FPU17/01567Xunta de Galicia ED431G-2019/06
6 · The paper itself

Abstract

The primary cilium is a sensory organelle that extends from the plasma membrane. It plays a vital role in physiological and developmental processes by controlling different signalling pathways such as WNT, Sonic hedgehog (SHh), and transforming growth factor β (TGF-β). Ciliary dysfunction has been related to different pathologies such as Alström (ALMS) or Bardet-Biedl (BBS) syndrome. The leading cause of death in adults with these syndromes is chronic kidney disease (CKD), which is characterised by fibrotic and inflammatory processes often involving the TGF-β pathway. Using genomic editing with CRISPR-CAS9 and phosphoproteomics we have studied the TGF-β signalling pathway in knockout (KO) models for ALMS1 and BBS1 genes. We have developed a network diffusion-based analysis pipeline to expand the data initially obtained and to be able to determine which processes were deregulated in TGF-β pathway. Finally, we have analysed protein-protein and kinase-substrate interactions to prioritise candidate genes in the regulation of the TGF-β pathway in ALMS and BBS. Analysis of differentially phosphorylated proteins identified 10 candidate proteins in the ALMS1 KO model and 41 in the BBS1 KO model. After network expansion using a random walk with a restart algorithm, we were able to identify the TGF-β signalling pathway together with other related processes such as endocytosis in the case of ALMS1 or the regulation of the extracellular matrix in BBS1. Protein interaction analyses demonstrated the involvement of CDC42 as a central protein in the interactome in ALMS1 and CDK2 in the case of BBS1. In conclusion, the depletion of ALMS1 and BBS1 affects the TGF-β signalling pathway, conditioning the phosphorylation and activation of several proteins, including CDC42 in the case of ALMS1 and CDK2 in the case of BBS1.

Indexed as

cdc42 GTP-Binding ProteinCyclin-Dependent Kinase 2Microtubule-Associated ProteinsPhosphoproteinsTransforming Growth Factor betaAnimalsBardet-Biedl SyndromeHumansMiceMice, KnockoutPhosphorylationProteomicsSignal Transductioncdc42 GTP-Binding ProteinCyclin-Dependent Kinase 2Microtubule-Associated ProteinsPhosphoproteinsTransforming Growth Factor betaALMS1Alström syndromeBardet–Biedl syndromeBBS1CiliopathiesPhosphoproteomicsTGF-β

Identifiers

PMID41193622
PMCPMC12589413

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.